F
FGK Rusgidro PAO
LSE:HYDR
FGK Rusgidro PAO
LSE:HYDR
Price:
0.53
USD
Market Closed
Market Cap:
4.3B
USD
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
HYDR Alert
FGK Rusgidro PAO
0.53
0.00 (0%)
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
FGK Rusgidro PAO
Balance Sheet
Balance Sheet Decomposition
FGK Rusgidro PAO
FGK Rusgidro PAO
| Current Assets | 193B |
| Cash & Short-Term Investments | 47.1B |
| Receivables | 85.1B |
| Other Current Assets | 60.9B |
| Non-Current Assets | 1T |
| Long-Term Investments | 42.8B |
| PP&E | 939.3B |
| Other Non-Current Assets | 24.5B |
| Current Liabilities | 213.5B |
| Accounts Payable | 35.9B |
| Accrued Liabilities | 38.5B |
| Short-Term Debt | 20.9B |
| Other Current Liabilities | 118.2B |
| Non-Current Liabilities | 338.9B |
| Long-Term Debt | 287B |
| Other Non-Current Liabilities | 51.9B |
Balance Sheet
FGK Rusgidro PAO
FGK Rusgidro PAO
Currency: RUB
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
34 394
|
48 025
|
67 354
|
70 156
|
65 432
|
41 047
|
58 291
|
59 806
|
36 923
|
32 364
|
|
| Cash |
14 977
|
11 888
|
14 760
|
11 127
|
19 981
|
15 488
|
13 738
|
17 922
|
18 984
|
23 555
|
|
| Cash Equivalents |
19 417
|
36 137
|
52 594
|
59 029
|
45 451
|
25 559
|
44 553
|
41 884
|
17 939
|
8 809
|
|
| Short-Term Investments |
40 388
|
19 846
|
4 454
|
946
|
30 030
|
46 858
|
41 415
|
509
|
445
|
0
|
|
| Total Receivables |
48 174
|
51 251
|
48 785
|
55 405
|
71 432
|
55 155
|
54 603
|
65 634
|
67 534
|
81 255
|
|
| Accounts Receivables |
32 288
|
34 917
|
33 036
|
34 708
|
36 256
|
35 495
|
34 607
|
34 899
|
38 858
|
47 328
|
|
| Other Receivables |
15 886
|
16 334
|
15 749
|
20 697
|
35 176
|
19 660
|
19 996
|
30 735
|
28 676
|
33 927
|
|
| Inventory |
22 133
|
23 999
|
24 037
|
25 523
|
30 721
|
34 386
|
35 149
|
38 871
|
50 882
|
58 943
|
|
| Other Current Assets |
3 287
|
2 519
|
3 823
|
3 089
|
11 337
|
10 779
|
16 851
|
8 251
|
8 514
|
6 544
|
|
| Total Current Assets |
148 376
|
145 640
|
148 453
|
155 119
|
208 952
|
188 225
|
206 309
|
173 071
|
164 298
|
179 106
|
|
| PP&E Net |
686 190
|
744 585
|
765 047
|
643 150
|
669 424
|
677 862
|
682 652
|
702 164
|
771 729
|
920 989
|
|
| PP&E Gross |
686 190
|
744 585
|
765 047
|
643 150
|
669 424
|
677 862
|
682 652
|
702 164
|
771 729
|
920 989
|
|
| Accumulated Depreciation |
35 729
|
36 106
|
39 992
|
42 031
|
50 390
|
36 247
|
35 579
|
42 685
|
43 191
|
47 730
|
|
| Goodwill |
929
|
481
|
481
|
481
|
481
|
481
|
481
|
481
|
481
|
0
|
|
| Long-Term Investments |
18 164
|
20 236
|
41 459
|
38 511
|
21 078
|
16 814
|
17 261
|
21 497
|
21 978
|
40 205
|
|
| Other Long-Term Assets |
30 111
|
27 195
|
28 006
|
34 442
|
31 996
|
41 737
|
35 332
|
33 274
|
34 914
|
24 053
|
|
| Other Assets |
929
|
481
|
481
|
481
|
481
|
481
|
481
|
481
|
481
|
0
|
|
| Total Assets |
883 770
N/A
|
938 137
+6%
|
983 446
+5%
|
871 703
-11%
|
931 931
+7%
|
925 119
-1%
|
942 035
+2%
|
930 487
-1%
|
993 400
+7%
|
1 164 353
+17%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
33 290
|
39 654
|
34 411
|
31 207
|
33 872
|
29 433
|
28 306
|
27 541
|
29 274
|
45 482
|
|
| Accrued Liabilities |
12 001
|
22 445
|
23 502
|
24 914
|
24 511
|
26 352
|
26 583
|
35 075
|
32 829
|
31 218
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
6 109
|
4 111
|
7 679
|
6 733
|
7 974
|
11 428
|
|
| Current Portion of Long-Term Debt |
57 843
|
62 214
|
41 757
|
78 613
|
32 790
|
35 324
|
68 385
|
65 614
|
74 091
|
57 145
|
|
| Other Current Liabilities |
18 716
|
13 141
|
16 986
|
16 514
|
22 796
|
28 084
|
16 790
|
18 822
|
30 043
|
29 106
|
|
| Total Current Liabilities |
121 850
|
137 454
|
116 656
|
151 248
|
120 078
|
123 304
|
147 743
|
153 785
|
174 211
|
174 379
|
|
| Long-Term Debt |
119 187
|
135 179
|
158 046
|
90 912
|
157 948
|
162 528
|
129 926
|
98 602
|
139 731
|
292 821
|
|
| Deferred Income Tax |
35 891
|
37 034
|
39 086
|
11 103
|
13 803
|
15 255
|
17 591
|
10 067
|
11 749
|
13 393
|
|
| Minority Interest |
16 230
|
11 440
|
4 263
|
9 106
|
9 818
|
4 211
|
9 353
|
9 702
|
16 607
|
14 871
|
|
| Other Liabilities |
11 691
|
14 551
|
18 726
|
48 832
|
53 883
|
54 157
|
37 835
|
38 680
|
37 518
|
38 552
|
|
| Total Liabilities |
304 849
N/A
|
335 658
+10%
|
336 777
+0%
|
311 201
-8%
|
355 530
+14%
|
359 455
+1%
|
342 448
-5%
|
310 836
-9%
|
379 816
+22%
|
534 016
+41%
|
|
| Equity | |||||||||||
| Common Stock |
386 255
|
386 255
|
386 255
|
426 289
|
426 289
|
426 289
|
439 289
|
439 289
|
439 289
|
444 793
|
|
| Retained Earnings |
179 556
|
203 114
|
243 790
|
99 624
|
115 523
|
104 786
|
125 709
|
145 773
|
139 709
|
151 002
|
|
| Additional Paid In Capital |
39 202
|
39 202
|
39 202
|
39 202
|
39 202
|
39 202
|
39 202
|
39 202
|
39 202
|
39 202
|
|
| Treasury Stock |
26 092
|
26 092
|
22 578
|
4 613
|
4 613
|
4 613
|
4 613
|
4 613
|
4 616
|
4 660
|
|
| Total Equity |
578 921
N/A
|
602 479
+4%
|
646 669
+7%
|
560 502
-13%
|
576 401
+3%
|
565 664
-2%
|
599 587
+6%
|
619 651
+3%
|
613 584
-1%
|
630 337
+3%
|
|
| Total Liabilities & Equity |
883 770
N/A
|
938 137
+6%
|
983 446
+5%
|
871 703
-11%
|
931 931
+7%
|
925 119
-1%
|
942 035
+2%
|
930 487
-1%
|
993 400
+7%
|
1 164 353
+17%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
364 469
|
364 469
|
367 403
|
422 437
|
422 437
|
422 437
|
435 437
|
435 437
|
435 432
|
440 885
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
